Contract

Total Cellular Pathology Solution

  • Regional Business Services Organisation Procurement and Logistics Service

F20: Modification notice

Notice identifier: 2025/S 000-013449

Procurement identifier (OCID): ocds-h6vhtk-04fe3e

Published 7 April 2025, 3:32pm



Section one: Contracting authority/entity

one.1) Name and addresses

Regional Business Services Organisation Procurement and Logistics Service

Supplies Centre, Gransha Hospital, Clooney Road

Derry

BT47 6YZ

Email

kieran.taylor@hscni.net

Country

United Kingdom

Region code

UK - United Kingdom

Internet address(es)

Main address

https://etendersni.gov.uk/epps

Buyer's address

https://etendersni.gov.uk/epps


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Total Cellular Pathology Solution

Reference number

454192

two.1.2) Main CPV code

  • 33000000 - Medical equipments, pharmaceuticals and personal care products

two.1.3) Type of contract

Supplies

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UKN06 - Belfast

two.2.4) Description of the procurement at the time of conclusion of the contract:

A total Cellular Pathology Solution to the Belfast Health and Social Care Trust

two.2.7) Duration of the contract, framework agreement, dynamic purchasing system or concession

Duration in months

6

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section four. Procedure

four.2) Administrative information

four.2.1) Contract award notice concerning this contract

Notice number: 2018/S 053-117088


Section five. Award of contract/concession

Contract No

454192

Title

total Cellular Pathology Solution

five.2) Award of contract/concession

five.2.1) Date of conclusion of the contract/concession award decision:

12 February 2018

five.2.2) Information about tenders

The contract/concession has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor/concessionaire

Roche Diagnostics Ltd

Charles Avenue

Burgess Hill

RH15 9RY

Email

burgesshill@roche.com

Country

United Kingdom

NUTS code
  • UK - United Kingdom
Internet address

https://www.roche.co.uk/

The contractor/concessionaire is an SME

No

five.2.4) Information on value of the contract/lot/concession (at the time of conclusion of the contract;excluding VAT)

Total value of the procurement: £19,985,768


Section six. Complementary information

six.4) Procedures for review

six.4.1) Review body

Business Services Organisation, Procurement Logistics Service

77 Boucher Crescent

Belfast

BT77 6HU

Country

United Kingdom

six.4.2) Body responsible for mediation procedures

Business Services Organisation, Procurement Logistics Service

77 Boucher Crescent

Belfast

BT77 6HU

Country

United Kingdom


Section seven: Modifications to the contract/concession

seven.1) Description of the procurement after the modifications

seven.1.1) Main CPV code

  • 33000000 - Medical equipments, pharmaceuticals and personal care products

seven.1.3) Place of performance

NUTS code
  • UKN06 - Belfast

seven.1.4) Description of the procurement:

Total Cellular Pathology Solution to the Belfast Health & Social Care Trust

seven.1.5) Duration of the contract, framework agreement, dynamic purchasing system or concession

Start date

16 July 2018

End date

15 July 2025

seven.1.6) Information on value of the contract/lot/concession (excluding VAT)

Total value of the contract/lot/concession:

£19,985,768

seven.1.7) Name and address of the contractor/concessionaire

Roche Diagnostics Ltd

Burgess Hill

RH15 9RY

Email

burgesshill@roche.com

Country

United Kingdom

NUTS code
  • UK - United Kingdom
National registration number

Charles Avenue

Internet address

https://www.roche.co.uk/

The contractor/concessionaire is an SME

No

seven.2) Information about modifications

seven.2.1) Description of the modifications

Nature and extent of the modifications (with indication of possible earlier changes to the contract):

A regional renewal tender is currently undergoing evaluation and cost analysis as DoH level.

A six month extension (with potential for extension for up to a further 6 months) to the

existing contract is being applied.

seven.2.2) Reasons for modification

Need for modification brought about by circumstances which a diligent contracting authority/entity could not foresee.

Description of the circumstances which rendered the modification necessary and explanation of the unforeseen nature of these circumstances:

A new regional tender renewal process has been initiated and is currently at evaluation stage

(see notice number 029933-002 on www.find-tender.service.gov.uk). The delay in awarding

this tender has been necessitated by regional digital change initiatives (introduction of a new

LIMS and a new NIPACS+ Radiography reporting system) and by extended cost evaluation

by DHPSS NI with the result being that this current contract is to be extended, as indicated,

to 13 September 2025 (with provision for up to 6 months further extension) to allow for

evaluation

and subsequent implementation. This extension is being conducted in line with Reg

72(1)(b)(ii)

of the 2015 PCR.

seven.2.3) Increase in price

Updated total contract value before the modifications (taking into account possible earlier contract modifications, price adaptions and average inflation)

Value excluding VAT: £19,985,768

Total contract value after the modifications

Value excluding VAT: £19,985,768